The effects of Prostaglandin J2 metabolite on selected apoptotic signaling molecules in UeLa cells

dc.contributor.authorNasir Aziz Rabail
dc.date.accessioned2021-03-10T08:44:39Z
dc.date.available2021-03-10T08:44:39Z
dc.date.issued2006
dc.description.abstractCancer of the cervix is one of the most rapidly increasing malignancies throughout the world and rated as the second most common cancer in Malaysian women. A ligand-dependent nuclear receptor, peroxisome proliferator-activated receptor gamma (PPARy) has been reported to be expressed in various cancer cells including breast, prostate, co lorecta I and cervical cance:r. Recently, down regulation of PPARy has been reported in human cervical carcinoma. Investigations have demonstrated that activation of PPARy is linked to growth inhibition of various cancers by induction of necrosis, apoptosis and growth arrest. This study aims to identify the effect of selective PPARy ligand, 15-Deoxyprostaglandin J2 (15d-PGJ2) on selected apoptotic molecules in the cervical cancer cell line, HeLa. HeLa cells were cultured and treated with an ECso dose of 15dPGJ2. These cells were harvested at every sixth hour of incubation period starting from 0 - 72 hours. Western bJot analysis revealed that Aid expression (anti apoptotic) was down regulated, while caspase 9 and caspase 3ยท (both are pro apoptotic) expression was up regulated. This finding provides significant evidence on the mechanism of apoptotic action of PPARy ligand that is potentially useful as a chemotherapeutic agent.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/11979
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan, Universiti Sains Malaysiaen_US
dc.subjectCancer cervixen_US
dc.titleThe effects of Prostaglandin J2 metabolite on selected apoptotic signaling molecules in UeLa cellsen_US
dc.typeOtheren_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: